Already a DIA Member? Sign in. Not a member? Join.

Sign in

Forgot User ID? or Forgot Password?

Not a Member?

Create Account and Join

Royal Tulip Brasília Alvorada Hotel

Sep 25, 2024 8:00 AM - Sep 26, 2024 4:00 PM

Shtn - Trechno 01, Conj 1Bb - Bloco C, 40800-200 Brasília, Brazil

Latin America Annual Meeting

Session 8, Track A: Regulation of Medicinal Products for Rare Disease: Challenges and Opportunities

Session Chair(s)

Viktoria  Magyar, LLM, MSC

Viktoria Magyar, LLM, MSC

Doctoral Student, Department of Regulatory and Quality Sciences, USC Alfred E. Mann School of Pharmacy and Pharmaceutical Sciences, United States

Cammilla  Horta Gomes, MA, MPHARM

Cammilla Horta Gomes, MA, MPHARM

Latam Regulatory Policy Lead , Roche, Brazil

This session will discuss the need to adopt regulatory framework, pathways, and tools to allow for timely access to medicinal products for rare diseases. Attention will be drawn to regulatory tools to prioritize or expedite the assessment and registration of treatments benefitting patients with rare diseases in Latin America. A discussion of international best practices and regional trends in the regulation of treatments for rare diseases, and how to bridge regulatory gaps through fostering discussions among regulators and industry representatives, will also be covered.

Learning Objective :
  • Recognize concepts and international best practices in the regulation of rare diseases
  • Identify current regulatory trends in Latin America
  • Understand the potential for evolving regulatory frameworks to facilitate greater access to innovative therapies for rare diseases
  • Capture the essence of a case study illustrating the use of priority registration pathway in Brazil

Speaker(s)

Daniela  Varela Luquetti, MD, PHD

Daniela Varela Luquetti, MD, PHD

Lead Clinical Analyst, CDER, FDA, United States

FDA Regulatory Considerations for Drug Development in Rare Diseases

Raquel  Pinheiro, MBA, RPH

Raquel Pinheiro, MBA, RPH

Regulatory Affairs Sr. Manager, Johnson & Johnson, Brazil

Rare Disease in Brazil: Case Study

Claudia  Saidman, DrMed, MD

Claudia Saidman, DrMed, MD

Director, Directorate of Clinical Research and Drug Registration Management, ANMAT Ministry of Health, Argentina

Speaker

Marlene  Esquivel, RPH

Marlene Esquivel, RPH

Department of Biological and Radiopharmaceuticals, DINAVISA, Paraguay

Speaker

Indhira  Johanna Bernuy Zagaceta

Indhira Johanna Bernuy Zagaceta

Executive Director of Pharmaceutical Products, DIGEMID, Peru

Speaker

Karina  Cuadra, RPH

Karina Cuadra, RPH

Head of Evaluation Sector, Ministry of Public Health - Uruguay , Uruguay

Speaker

Have an account?

Be informed and stay engaged.

Don't miss an opportunity - join our mailing list to stay up to date on DIA insights and events.